Levy Y - Search Results

1

IL-2 therapy: potential impact of the CD4 cell count at initiation on clinical efficacy--results from the ANRS CO4 cohort.

Fontas E, Kousignian I, Pradier C, Poizot-Martin I, Durier C, Weiss L, Levy Y, Costagliola D; FHDH ANRS CO4; ANRS CO14. Fontas E, et al. Among authors: levy y. J Antimicrob Chemother. 2010 Oct;65(10):2215-23. doi: 10.1093/jac/dkq296. Epub 2010 Aug 11. J Antimicrob Chemother. 2010. PMID: 20702463

2

Effects of interleukin-2 therapy combined with highly active antiretroviral therapy on immune restoration in HIV-1 infection: a randomized controlled trial.

Levy Y, Durier C, Krzysiek R, Rabian C, Capitant C, Lascaux AS, Michon C, Oksenhendler E, Weiss L, Gastaut JA, Goujard C, Rouzioux C, Maral J, Delfraissy JF, Emilie D, Aboulker JP; ANRS 079 Study Group. Levy Y, et al. AIDS. 2003 Feb 14;17(3):343-51. doi: 10.1097/00002030-200302140-00008. AIDS. 2003. PMID: 12556688 Clinical Trial.

3

Human immunodeficiency virus-driven expansion of CD4+CD25+ regulatory T cells, which suppress HIV-specific CD4 T-cell responses in HIV-infected patients.

Weiss L, Donkova-Petrini V, Caccavelli L, Balbo M, Carbonneil C, Levy Y. Weiss L, et al. Among authors: levy y. Blood. 2004 Nov 15;104(10):3249-56. doi: 10.1182/blood-2004-01-0365. Epub 2004 Jul 22. Blood. 2004. PMID: 15271794 Free article.

4

Immunological and virological efficacy of a therapeutic immunization combined with interleukin-2 in chronically HIV-1 infected patients.

Lévy Y, Gahéry-Ségard H, Durier C, Lascaux AS, Goujard C, Meiffrédy V, Rouzioux C, El Habib R, Beumont-Mauviel M, Guillet JG, Delfraissy JF, Aboulker JP; ANRS 093 Study Group. Lévy Y, et al. AIDS. 2005 Feb 18;19(3):279-86. AIDS. 2005. PMID: 15718838 Clinical Trial.

5

Sustained control of viremia following therapeutic immunization in chronically HIV-1-infected individuals.

Lévy Y, Durier C, Lascaux AS, Meiffrédy V, Gahéry-Ségard H, Goujard C, Rouzioux C, Resch M, Guillet JG, Kazatchkine M, Delfraissy JF, Aboulker JP; ANRS 093 Study Group. Lévy Y, et al. AIDS. 2006 Feb 14;20(3):405-13. doi: 10.1097/01.aids.0000206504.09159.d3. AIDS. 2006. PMID: 16439874 Clinical Trial.

6

Clinical safety of HIV lipopeptides used as vaccines in healthy volunteers and HIV-infected adults.

Durier C, Launay O, Meiffrédy V, Saïdi Y, Salmon D, Lévy Y, Guillet JG, Pialoux G, Aboulker JP. Durier C, et al. Among authors: levy y. AIDS. 2006 Apr 24;20(7):1039-49. doi: 10.1097/01.aids.0000222077.68243.22. AIDS. 2006. PMID: 16603857

7

Long-term effects of intermittent interleukin-2 therapy in chronic HIV-infected patients (ANRS 048-079 Trials).

Durier C, Capitant C, Lascaux AS, Goujard C, Oksenhendler E, Poizot-Martin I, Viard JP, Weiss L, Netzer E, Delfraissy JF, Aboulker JP, Lévy Y. Durier C, et al. Among authors: levy y. AIDS. 2007 Sep 12;21(14):1887-97. doi: 10.1097/QAD.0b013e3282703825. AIDS. 2007. PMID: 17721096 Clinical Trial.

8

Switch from zidovudine- to non-zidovudine-containing regimens is associated with modest haematological improvement and no obvious clinical benefit: a substudy of the ANRS 099 ALIZE trial.

Lafaurie M, Collin F, Bentata M, Garré M, Leport C, Levy Y, Goujard C, Chêne G, Molina JM; ALIZE Study Group. Lafaurie M, et al. Among authors: levy y. J Antimicrob Chemother. 2008 Nov;62(5):1122-9. doi: 10.1093/jac/dkn309. Epub 2008 Jul 28. J Antimicrob Chemother. 2008. PMID: 18662943 Clinical Trial.

9

HIV-specific regulatory T cells are associated with higher CD4 cell counts in primary infection.

Kared H, Lelièvre JD, Donkova-Petrini V, Aouba A, Melica G, Balbo M, Weiss L, Lévy Y. Kared H, et al. Among authors: levy y. AIDS. 2008 Nov 30;22(18):2451-60. doi: 10.1097/QAD.0b013e328319edc0. AIDS. 2008. PMID: 19005268 Free PMC article.

10

Interleukine-2 therapy does not increase the risk of Hodgkin or non-Hodgkin lymphoma in HIV-infected patients: results from FHDH ANRS CO4.

Fontas E, Kousignian I, Pradier C, Duvivier C, Poizot-Martin I, Durier C, Jarrousse B, Weiss L, Levy Y, Costagliola D; FHDH ANRS CO4 ANRS CO141. Fontas E, et al. Among authors: levy y. J Acquir Immune Defic Syndr. 2009 Feb 1;50(2):206-14. doi: 10.1097/QAI.0b013e318190018c. J Acquir Immune Defic Syndr. 2009. PMID: 19131886

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,334 results

Search Page